相似文献
1
Diverse Underlying Mechanisms and Sex Differences Found in Translational Models of Cannabinoids Use: Towards Validation in Human Studies.
Int J Mol Sci. 2023 Nov 22;24(23):16586. doi: 10.3390/ijms242316586.
2
Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?
Life Sci. 2013 Mar 19;92(8-9):476-81. doi: 10.1016/j.lfs.2012.06.009. Epub 2012 Jun 20.
3
Endocannabinoids, cannabinoids and the regulation of anxiety.
Neuropharmacology. 2021 Sep 1;195:108626. doi: 10.1016/j.neuropharm.2021.108626. Epub 2021 Jun 8.
4
Sex differences in the interactive effects of early life stress and the endocannabinoid system.
Neurotoxicol Teratol. 2020 Jul-Aug;80:106893. doi: 10.1016/j.ntt.2020.106893. Epub 2020 May 11.
5
Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids.
Curr Top Behav Neurosci. 2018;39:153-173. doi: 10.1007/7854_2016_24.
6
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
Prog Lipid Res. 2013 Jan;52(1):80-109. doi: 10.1016/j.plipres.2012.10.001. Epub 2012 Oct 26.
7
Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.
J Neuroimmune Pharmacol. 2010 Mar;5(1):103-21. doi: 10.1007/s11481-009-9177-z. Epub 2009 Oct 22.
8
Endocannabinoids: new targets for drug development.
Curr Pharm Des. 2000 Sep;6(13):1361-80. doi: 10.2174/1381612003399365.
9
The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases.
Eur J Pharmacol. 2021 Nov 15;911:174560. doi: 10.1016/j.ejphar.2021.174560. Epub 2021 Oct 11.
10
Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective.
Neuropsychopharmacology. 2018 Jan;43(1):34-51. doi: 10.1038/npp.2017.140. Epub 2017 Jul 17.
本文引用的文献
1
Gender-based research underscores sex differences in biological processes, clinical disorders and pharmacological interventions.
Biochem Pharmacol. 2023 Sep;215:115737. doi: 10.1016/j.bcp.2023.115737. Epub 2023 Aug 6.
2
Modulatory Activity of the Endocannabinoid System in the Development and Proliferation of Cells in the CNS.
Neurotox Res. 2022 Dec;40(6):1690-1706. doi: 10.1007/s12640-022-00592-6. Epub 2022 Dec 16.
3
Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?
J Pers Med. 2022 Oct 14;12(10):1719. doi: 10.3390/jpm12101719.
4
Multimodal Investigations of Reward Circuitry and Anhedonia in Adolescent Depression.
Front Psychiatry. 2021 Jul 23;12:678709. doi: 10.3389/fpsyt.2021.678709. eCollection 2021.
5
Depression and the willingness to expend cognitive and physical effort for rewards: A systematic review.
Clin Psychol Rev. 2021 Aug;88:102065. doi: 10.1016/j.cpr.2021.102065. Epub 2021 Jul 7.
6
Discovering the Lost Reward: Critical Locations for Endocannabinoid Modulation of the Cortico-Striatal Loop That Are Implicated in Major Depression.
Int J Mol Sci. 2021 Feb 13;22(4):1867. doi: 10.3390/ijms22041867.
7
Endocannabinoid system in trauma and psychosis: distant guardian of mental stability.
Rev Neurosci. 2021 Mar 1;32(7):707-722. doi: 10.1515/revneuro-2020-0102. Print 2021 Nov 25.
8
Alterations in Rat Accumbens Dopamine, Endocannabinoids and GABA Content During WIN55,212-2 Treatment: The Role of Ghrelin.
Int J Mol Sci. 2020 Dec 28;22(1):210. doi: 10.3390/ijms22010210.
9
Meet Your Stress Management Professionals: The Endocannabinoids.
Trends Mol Med. 2020 Oct;26(10):953-968. doi: 10.1016/j.molmed.2020.07.002. Epub 2020 Aug 28.
10
Early life stress and development of the endocannabinoid system: A bidirectional process in programming future coping.
Dev Psychobiol. 2021 Mar;63(2):143-152. doi: 10.1002/dev.21944. Epub 2019 Dec 18.
Zotero 插件